 OUTLINE: Patients are stratified according to conditioning regimen fludarabine phosphate and melphalan vs fractionated total-body irradiation FTBI and etoposide vs FTBI and cyclophosphamide and degree of donorrecipient HLA mismatch high-risk vs low-risk. 